Off the wire
German factory orders rebound in March  • Ministers mull intra-Africa tourism to increase arrivals  • 1st LD: Acting speaker of Brazil lower house annuls impeachment vote against Rousseff  • Two Kenyans fined USD200,000 for dealing with wildlife trophies  • 2nd LD Writethru: Duterte still leading in Philippine presidential election with 82 percent votes counted  • 97 expedition teams off to different peaks of Nepal this season  • Roundup: SA government pledges to address structural constraints to economic growth  • 1st LD: At least 10 killed in car bomb blast in Iraq's Diyala  • Top Republican leader Ryan says he would step down if Trump asks  • Khartoum vows to rule out moves that may destabilize S. Sudan  
You are here:   Home

1st LD-Writethru: Investigation confirms hospital malpractice in cancer treatment

Xinhua, May 10, 2016 Adjust font size:

China's health and military authorities on Monday said an investigation confirmed wrongdoing by a military hospital in Beijing in the treatment of a young cancer patient.

The No.2 Hospital of CAPF Beijing Corps was found to have published incorrect information, posted misleading advertisements and to have violated regulations on working with the private sector, said a statement from the National Health and Family Planning Commission (NHFPC).

Wei Zexi, a 21-year-old college student who died last month of a rare form of cancer, had undergone a clinically unproven treatment at the hospital.

Before his death, Wei expressed anger at the hospital and China's leading search engine Baidu in an online post, accusing them of falsely claiming a high success rate for the treatment.

The investigation by the NHFPC, and logistic support departments of the Central Military Commission and the Chinese People's Armed Police Force (CAPF) began on May 3.

Wei was diagnosed with synovial sarcoma, a rare form of cancer, in 2014 and had been undergoing the treatment that the hospital claimed uses cells generated by his own immune system to counter the illness.

The treatment -- a joint project between the hospital and a private company, Shanghai Claison Bio-tech Co. Ltd -- cost Wei's family around 200,000 yuan (about 31,000 U.S. dollars) and was unsuccessful. He died on April 12.

The hospital has been asked to terminate all projects outsourced to medical service providers, including the Shanghai firm.

The investigation found Li Zhiliang, the physician in charge of Wei's treatment, was not a former hospital employee and his behavior violated protocol, though the investigators did not specify.

Doctor licenses of Li and some other hospital staff are believed to have been revoked. The investigators said some may be prosecuted.

The hospital must immediately terminate all advertising contracts with media outlets, and any misleading information will be removed from the public domain. It must also make improvements to its internal procedures, said the statement.

The military will overhaul advertising of their hospitals and actively cooperate with the health department in supervising them.

There will be an overhaul of all joint projects between military hospitals and private companies, according to the statement. Endi